OCS Oculis Holding AG
$10.13▼ -4.48%
Healthcare
Other
Volume 48.8K
Avg Volume (10D) 153.4K
Key Metrics & Fundamentals
Market Cap
$562.22M
P/E Ratio
–
Div Yield
–%
52W Range
10.05 - 34.48
% vs 50 MA
-14.16%
% vs 200 MA
-49.14%
RSI-14
24.5
MACD Histogram
-0.2100
Beta (1Y vs SPY)
0.99
Free Cash Flow
-$20.25M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$22.80M
COGS
–
Operating Exp
$23.57M
Operating Income
-$23.57M
EBIT
-$23.57M
Pretax Income
-$9.96M
Net Income
-$9.97M
EPS (Diluted)
-0.16
Price & Volume History
Loading chart…
Recent News
Wall Street Analysts Believe Oculis Holding AG (OCS) Could Rally 199.75%: Here's is How to Trade
Zacks · Aug 31, 2026 1:55 PM
Oculis Treats First Patient in Optic Neuritis Trial; Shares Up Pre-Bell
MT Newswires · Aug 24, 2026 9:41 AM
First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis
GlobeNewswire · Aug 24, 2026 8:00 AM
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
GlobeNewswire · Aug 14, 2026 8:05 PM
Does Oculis Holding AG (OCS) Have the Potential to Rally 187.83% as Wall Street Analysts Expect?
Zacks · Aug 14, 2026 1:55 PM
Oculis to Buy Accure's Global Development, Commercial Rights to Privosegtor
MT Newswires · Aug 10, 2026 8:45 AM
Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company
GlobeNewswire · Aug 10, 2026 7:30 AM
Oculis Holding AG (OCS) Reports Q2 Loss, Tops Revenue Estimates
Zacks · Aug 7, 2026 2:35 AM
Oculis Reports Q2 2026 Financial Results and Provides Company Update
GlobeNewswire · Aug 6, 2026 8:05 PM
Earnings To Watch: Oculis Holding AG (OCS) Reports Q2 2026 Result
GuruFocus.com · Aug 5, 2026 1:33 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See OCS's money flow as a full page
Social Sentiment
Avg +0.55 · 4 posts
DD$154k yolo into $TMDX
r/wallstreetbets · May 21, 2026
OCS is presented as a key component of TMDX's competitive advantage.
positive
+0.60
NewsDiscussionAuxly getting some OSC love
r/wallstreetbets · Jan 9, 2026
The post expresses 'OSC love' and references a large greenhouse project, suggesting positive sentiment.
positive
+0.60
DiscussionFavorite mid-cap biotech with the most upside? (500M–2.5B mkt cap)
r/investing · Dec 22, 2025
Mentioned as a potential investment.
positive
+0.50
DDDiscussionHere’s my next play: $TMDX
r/wallstreetbets · Nov 30, 2025
Discussed in context of TMDX, indicating a positive outlook on the related product.
positive
+0.50
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.